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Abstract: The aim of the present study was to monitor serum tartrate-resistant acid phosphatase (TRAP) and C-terminal
telopeptide fragments of type I collagen (CTX) over time in canine experimental osteotomies fixed using 2 osteosynthesis
techniques, to determine the relevance of both markers in monitoring bone healing, and to investigate the influence of
the 2 osteosynthesis techniques on their concentrations. Transperiosteal osteotomy of the diaphyses of the right tibia
and fibula was performed in 12 dogs. The dogs were then randomly assigned to 1 of 2 groups: group 1 (6 dogs) underwent
osteotomy fixed with intramedullary osteosynthesis (IMO) and group 2 (6 dogs) underwent osteotomy fixed with a plate
(plate osteosynthesis [PLO]). Craniocaudal radiographs were obtained immediately after osteosynthesis, 2 weeks postsurgery and 1, 2, 3, 4, 5, and 6 months post-surgery. The evaluation of bone resorption was performed visually using a
4-grade scoring system. At the same time points, venous blood was sampled for determination of tartrate-resistant acid
phosphatase and the concentration of C-terminal telopeptide fragments of type I collagen.
Radiologically visible bone resorption was characterized by 2 peaks. The 1st peak occurred by the end of the 2nd
postoperative week with both osteosynthesis methods (P < 0.001). The 2nd peak began by the end of the 4th postoperative
month and persisted until the end of the experiment.
Serum TRAP was not a reliable marker of bone resorption during the study period. CTX concentrations increased
considerably in both groups by the end of the 1st postoperative month (P < 0.05), decreased by the 3rd postoperative
month, and increased again by the end of the 5th postoperative month. CTХ, therefore, could be used to monitor normal
bone healing.
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Introduction
Bone metabolism is characterized by bone
formation and bone resorption. Modeling and
remodeling are 2 key features of bone healing (1). In
modeling, bone formation and resorption are
independent with regard to space and time, whereas

remodeling is effectuated by alternating bone removal
and transposition from specified places via the
coordinated activity of osteoclasts and osteoblasts (2).
Bone remodeling alters the internal bone
architecture and is dependent on such conditions as
loading, micro-trauma, nutritive and hormonal
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effects, post-fracture conditions, and inflammation
(3). In healthy mature individuals (humans and
animals) the processes are balanced and there is no
change in bone mass.
Complete assessment of the cellular basis of bone
pathology requires methods and techniques for
separately monitoring bone formation and bone
resorption. A good approach is the utilization of
blood and urine biochemical bone markers. Ideally,
bone markers are specific for bone cell activity in the
clinical setting and should not be influenced by
alterations in non-osseous metabolism.
Degradation fragments of collagen type I from the
N- and C-regions of the molecule (known as NTX
and CTX) can be quantified in serum and urine. A
variant of CTX (ICTP) can be measured in blood
serum (3) and is not dependent on renal clearance
rates (4). NTX and CTX urinary levels are dependent
on renal clearance and thus need to be corrected
based on urinary creatinine excretion. These 3
markers can be used in animals.
Circadian rhythm was reported to be a bone
marker in rats (5), mice (6), rabbits, and horses (7).
Osteocalcin and ICTP activity in dogs is higher in the
morning than in the afternoon. In both dogs and
humans the variations are lower in serum than in
urine samples (8,9).
The current veterinary medical literature includes
reports of bone markers being used to detect
differences in bone formation and bone resorption in
horses (10,11), dogs (12), and cats (13,14). Lammens
et al. (15) and Theyse et al. (16) followed up
distraction osteogenesis of the tibia using these
markers and growth factors; however, both teams
obtained conflicting results.
The bone markers in dogs were studied on a rather
theoretical level with regard to age- and breed-related
differences (9,12,17). A few reports exist on their
application in clinical practice with regard to
osteomyelitis (18), radial ostectomy (19), and
monitoring normal healing of long bone fractures (20).
The aim of the present study was to monitor serum
levels of tartrate-resistant acid phosphatase (TRAP)
and C-terminal telopeptide fragments of type I
collagen (CTX) over time in experimental
osteotomies in dogs fixed using 2 osteosynthesis
228

techniques, to determine the relevance of both bone
markers in monitoring bone healing and the influence
of each osteosynthesis technique on their
concentrations as bone resorption markers.
Мaterials and methods
Animals
The study included 12 mixed-breed male dogs
aged 2-5 years and weighing 12-20 kg. The animals
were obtained from a licensed kennel and at the end
of the study were returned. The dogs were housed in
individual cages, fed a commercial dry food for adult
dogs (Jambo-dog, Gallisman-94 S.A., Bulgaria), and
received water ad libitum. Prior to the study all dogs
were treated for ecto- and endoparasites. The study
was approved by the Trakia University Committee on
Animal Experimentation, Stara Zagora, Bulgaria, and
was performed according to the Animal Welfare Act
No. 25/10.06.05 and the Veterinary and Medical
Activities Law.
Operative protocol
The anesthetic protocol included premedication
with atropine sulphate (0.02 mg/kg s.c.) (Sopharma,
Bulgaria) and acepromazine maleate (0.05 mg/kg
i.m.) (Neurotranq, Alfasan, Woerden, Holland),
induction with 2.5% thiopentone sodium (6 mg/kg
i.v.) (Thiopental, Biochemie GmbH, Kudl, Austria),
intubation, and maintenance of general anesthesia
with 2.5 vol.% halothane (Narcotan, Spofa, Czech
Republic).
Following aseptic preparation and medial
treatment, transperiosteal osteotomy of the diaphyses
of the right tibia and fibula was performed in all the
dogs. Then the dogs were randomly assigned to 1 of 2
groups and treated as follows: group 1 (6 dogs):
osteotomies were fixed with normograde insertion of
a Kuntscher nail in the medullar canal
(intramedullary osteosynthesis, IMO); group 2 (6
dogs): osteotomies were fixed with a plate and 6
cortical screws (3 in the distal and 3 in the proximal
bone fragment) (plate osteosynthesis [PLO]).
Soft tissues were sutured routinely and protective
bandages were placed on the crural area.
Postoperatively the animals were treated for pain with
butorphanol tartrate (0.2 mg/kg, s.c.) (Torbutrol, Fort
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Dodge, USA). An intramuscular antibiotic
combination of lincomycin (50 mg/mL) and
spectinomycin (100 mg/mL) (Linco-Spectin,
Pharmacia N.V./S.A., Puurs, Belgium) was
administered at 1 mL/5 kg for 4 days following
surgery.

quantified using a Serum CrossLaps® ELISA kit
(Nordic Bioscience, Denmark), which measures
degradation products of C-telopeptide fragments of
type I collagen in blood with a precision of 0.02
ng/mL. Each sample was analyzed in duplicate and
the mean of both measurements was obtained.

Clinical observations

Statistical analysis

After surgery the following clinical parameters
were monitored: rectal body temperature, heart and
respiratory rates, appetite, and state of the operated
limb.
Radiography
Craniocaudal radiographs of the operated limbs
were obtained immediately after osteosynthesis, at
postoperative week 2, and at postoperative months 1,
2, 3, 4, 5, and 6. They were examined to determine
bone resorption and remodeling events by means of a
scoring system that allowed for conversion of
qualitative evaluation into quantitative parameters
(Table 1). Scores at each time point were compared to
the scores obtained immediately after surgery. All
radiographs were interpreted independently by 2
radiologists blinded to the post-osteosynthesis period.
Mean scores of both observers were calculated.
Blood serum bone markers assays
Venous blood samples were obtained prior to
surgery, and at postoperative week 2 and
postoperative months 1, 2, 3, 4, 5, and 6. Blood
samples were collected between 0730 and 0800 to
eliminate any circadian effects.
Tartrate-resistant acid phosphatase (TRAP) was
assayed immediately after separation of sera using a
colorimetric kit (Biolabo SA, France). C-terminal
telopeptide fragments of collagen type I were

Data were statistically analyzed using the nonparametric Friedman’s test for 2-way repeated
measures. In the case of significant P values the nonparametric Tukey’s HSD test was then applied.
Differences between the groups at each time point
were tested via the Mann-Whitney U test.
Results
Clinical results
During the postoperative period the dogs did not
exhibit any deviation in the general clinical
parameters. Rectal body temperature, and respiratory
and heart rates were within reference ranges, and the
dogs’ appetites were good.
In the crural region of the operated limbs there
was moderate, slightly painful warm swelling that
disappeared within 4-6 days. During the first postosteosynthesis day the dogs were predominantly lying
down, then manifested grade 2-3 weight-bearing
lameness (lasting for up to 1 week in PLO dogs and
up to 2-3 weeks in IMO dogs). After that period full
weight bearing was resumed.
Radiological studies
The results of radiological examinations are shown
in Figures 1 and 2, and Table 2. Radiologically visible
bone resorption was characterized by 2 peaks in both

Таble 1. Scoring system for bone resorption evaluation.
Description

Score

No signs of bone resorption

0

Decreased bone density near the site of osteotomy

1

Decreased bone density near and far from the site of osteotomy

2

Bone callus remodeling

3
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Figure 1. Craniocaudal radiographs of the tibia of a dog from the IMO group
immediately after the osteosynthesis (A) and at postoperative week 2 (B) and
months 1, 2, 3, 4, 5, and 6 (from C to H, respectively).
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Figure 2. Craniocaudal radiographs of the tibia of a dog from the PLO group
immediately after the osteosynthesis (A) and at postoperative week 2 (B) and
months 1, 2, 3, 4, 5, and 6 (from C to H, respectively).

Таble 2. Mean radiological scores of bone resorption and remodeling in dogs after osteotomy fixed by 2 osteosynthesis techniques.
Time after surgery
Parameter

Bone resorption
and remodeling

Osteosynthesis

2 weeks

1 month

2 months

3 months

4 months

5 months

6 months

IMO
(n = 6)

1.00 ± 0.00***

1.16 ± 0.30**

1.16 ± 0.40

0.83 ± 0.40

3.00 ± 0.00***

3.00 ± 0.00***

3.00 ± 0.00***

PLО
(n = 6)

1.33 ± 0.21***

1.50 ± 0.34**

0.50 ± 0.22

0.83 ± 054

2.33 ± 0.42***

3.00 ± 0.00**

3.00 ± 0.00***

IMO – intramedullary osteosynthesis; PLO – plate osteosynthesis; *P < 0.05; ** P < 0.01; *** P < 0.001 vs. the preceding period.
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groups. The first occurred by the end of the second
postoperative week in both groups (P < 0.001). The
second peak was observed by the end of the fourth
postoperative month and persisted until the end of the
study.
Dynamics of bone markers
Changes in the blood concentration of the studied
biochemical markers are presented in Table 3.
Tartrate-resistant acid phosphatase (TRAP) did not
change significantly during the study in either group.
There were, however, alterations in serum C-terminal
telopeptide fragments of type I collagen (СТX). CTX
increased considerably in the IMO group by the end
of the 1st postoperative month (from 1.05 ± 0.11
ng/mL at baseline to 1.85 ± 0.13 ng/mL [P < 0.05]),
decreased by the 3rd postoperative month, and
increased again by the end of the 5th postoperative
month. In the PLO group the values also increased by
the end of the 1st postoperative month (from 1.05 ±
0.11 ng/mL to 1.86 ± 0.10 ng/mL [P < 0.05]), but
returned to baseline, and then increased significantly
again by the end of the 6th postoperative month (1.69
± 0.19 ng/mL [P < 0.05]).
Discussion
Type I collagen is composed of collagen molecules
bound by their amino- and carboxy-terminal groups.
The bridges between them are made of pyridine,

deoxypyridinoline, and pyridinoline. Degradation of
type I collagen during bone resorption is performed
by an osteoclastic protease (acid phosphatase), and
telopeptides and disrupted bonds are released as end
products.
Osteogenesis during bone fracture or experimental
long bone osteotomy healing is performed via
endochondral ossification, unlike distraction
osteogenesis in which the process is mediated via
intramembranous ossification (21). This means that
the first cases involve stages of fibrous, cartilaginous,
and bone callus that gradually evolve from one into
the other. Duration of the stages varies by species, the
type and site of the fracture, fracture stability after
osteosynthesis, status of the surrounding soft tissues,
etc. The bone callus becomes radiologically visible
only when mineralization (ossification) islets begin to
appear (22). In the present study all conditions were
the same in both groups, with the exception of the
osteosynthesis technique used. It is known that plate
osteosynthesis provides better stability than
intramedullary osteosynthesis; therefore, more
extensive bone reaction in intramedullary fixed
osteotomies could be expected. This was also
confirmed in the present study. There was a
statistically significant difference between the groups
in bone formation rates by the end of the 1st month
(higher in the IMO group) and the 3rd month (higher
in the PLO group) (23). The callus was, however,

Таble 3. Changes in blood concentrations of studied biochemical resorption markers in dogs after osteotomy fixed by 2 osteosynthesis
techniques.
Time after surgery
Parameter

Tartrateresistant
acid
phosphatase,
U/L

CTX, ng/mL

Prior to
surgery

2.60 ± 0.53
(n=12)

1.05 ± 0.11
(n=12)

Osteosynthesis

2 weeks

1 month

2 months

3 months

4 months

5 months

6 months

IMO
(n=6)

3.48 ± 0.45

2.11 ± 0.27

2.31 ± 0.43

1.94 ± 0.44

3.59 ± 0.96

2.92 ± 0.40

2.58 ± 0.35

PLО
(n=6)

1.72 ± 0.27

2.02 ± 0.34

3.00 ± 0.53

3.45 ± 0.69

3.95 ± 0.68

3.14 ± 0.45

3.71 ± 0.68

IМО
(n=6)
PLО
(n=6)

1.33 ± 0.09

1.85 ± 0.13*

1.74 ± 0.14*

1.47 ± 0.26

1.50 ± 0.15*

1.52 ± 0.20*

1.21 ± 0.14

1.28 ± 0.11

1.86 ± 0.10*

1.51 ± 0.23

1.26 ± 0.11

1.36 ± 0.08

1.38 ± 0.20

1.69 ± 0.19*

IMO – intramedullary osteosynthesis; PLO – plate osteosynthesis; *P < 0.05 vs. baseline (prior to surgery).
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visualized as early as the end of the 2nd postoperative
week, indicating the beginning of the mineralization
of newly formed bone tissue.
By the end of the first month of fracture healing
bone resorption was the result of inflammation,
whereas by the end of the study it was directed
towards remodeling and smoothing of bone callus
(24). In the present study bone resorption was clearer
by the end of the study when the callus was
undergoing remodeling, but the osteosynthesis
technique did not significantly affect this process.
In the present study we monitored 2 markers of
bone resorption: tartrate-resistant acid phosphatase
(TRAP) and the carboxy-terminal telopeptide
fragments of collagen type I (CTХ). The first marker
did not exhibit significant differences, although there
were radiographic signs of bone resorption, both at
the beginning and by the end of the study. This might
have been due to the fact that we monitored total
TRAP and that mammalian serum is known to
contain 2 forms (5a and 5b); however, only 5b-TRAP
was released by osteoclasts and was a marker of their
activity. The 5a form is of non-osseous origin (25).
Our results confirm the opinion that total serum
TRAP is not a specific marker of bone resorption. The
other marker we used is a metabolite(s) of collagen
type I degradation. Theyse et al. (16) reported that
even the insertion of a fixation device without
osteotomy provoked a bone reaction and resulted in
early (by the 2nd week) elevation of carboxy-terminal
telopeptide of collagen type I (ICTP) concentrations.

In our previous studies on intramedullary fixed
canine femoral osteotomy, we observed an increase
in serum ICTP levels by the 1st and the 2nd
postoperative week, and then a subsequent decrease
(21). In the same experimental design, but
complicated by experimental osteomyelitis, high
ICTP levels persisted until the end of the 4th
postoperative week (19). The present study
confirms that intramedullary nailing is more
invasive to the bone. CTX concentrations in the
present study increased significantly, as compared
to baseline, in both groups by the 1st postoperative
month; in the IMO group by the 2nd, 4th, and 5th
months, and in the PLO group by the 6th month,
and the difference between the groups was not
statistically significant. It could be concluded that
CTХ was reliable for monitoring normal bone
healing because alterations in its concentration
corresponded with resorption of bone ends
immediately after trauma (osteotomy or fracture),
and then decreased and increased again at a later
stage when newly formed bone callus underwent
remodeling. This event occurred at different time
points when different osteosynthesis techniques
were used.
In conclusion, total serum tartrate-resistant acid
phosphatase was not a reliable marker of bone
resorption during the study period. Serum levels of
C-terminal telopeptide fragments of type I collagen
(CTХ), however, could be used to monitor normal
bone healing.
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